CAPTRUST Financial Advisors
NVAX icon

CAPTRUST Financial Advisors’s Novavax NVAX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-18,675
Closed -$176K – 3567
2026
Q2 		$176K Buy
+18,675
New +$167K ﹤0.01% 2923
2022
Q3 		– Sell
-6,703
Closed -$345K – 3352
2022
Q2 		$345K Buy
6,703
+3,047
+83% +$158K ﹤0.01% 1343
2022
Q1 		$269K Sell
3,656
-44
-1% -$3.92K ﹤0.01% 1519
2021
Q4 		$529K Buy
3,700
+1,133
+44% +$195K ﹤0.01% 1092
2021
Q3 		$532K Buy
2,567
+1,942
+311% +$428K ﹤0.01% 1001
2021
Q2 		$133K Buy
625
+16
+3% +$2.93K ﹤0.01% 1804
2021
Q1 		$110K Buy
609
+399
+190% +$79.5K ﹤0.01% 1885
2020
Q4 		$23K Buy
210
+27
+15% +$2.87K ﹤0.01% 2183
2020
Q3 		$19K Sell
183
-37
-17% -$4.51K ﹤0.01% 1998
2020
Q2 		$18K Buy
+220
New +$8.41K ﹤0.01% 1981

Other funds holding NVAX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Shah Capital Management
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

CAPTRUST Financial Advisors's NVAX Position: Q3 2026 in Review

CAPTRUST Financial Advisors sold out of Novavax (NVAX) in Q3 2026, closing a stake of 18,675 shares — an estimated $176K sold.

CAPTRUST Financial Advisors first reported a position in NVAX in Q2 2020 and held it in 10 quarters. The position peaked at $532K in Q3 2021. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • CAPTRUST Financial Advisors reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 18,675 Novavax shares in Q3 2026, an estimated $176K.
  • CAPTRUST Financial Advisors first reported a position in Novavax in Q2 2020 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Novavax position peaked at $532K in Q3 2021.
  • 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.